Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Hematology/Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Ineffective erythropoiesis in beta-thalassaemia: key steps and therapeutic options by drugs.Int J Mol Sci. 2021; 22: 7229
- Erythropoiesis, EPO, macrophages, and bone.Bone. 2019; 119: 36-41
- insights into pathophysiology and treatments in 2017.Mol Med. 2018; 24: 1-15
- Ineffective erythropoiesis: anemia and iron overload.Hematol Oncol Clin North Am. 2018; 32: 213-221
- Population snapshots predict early haematopoietic and erythroid hierarchies.Nature. 2018; 555: 54-60
- Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis.Proc Natl Acad Sci U S A. 2009; 106: 17413-17418
- Characterization, regulation, and targeting of erythroid progenitors in normal and disordered human erythropoiesis.Curr Opin Hematol. 2017; 24: 159-166
- Global transcriptome analyses of human and murine terminal erythroid differentiation.Blood. 2014; 123: 3466-3477
- Erythroblastic islands: niches for erythropoiesis.Blood. 2008; 112: 470-478
- Erythroblastic islands: specialized microenvironmental niches for erythropoiesis.Curr Opin Hematol. 2006; 13: 137-141
- The erythroid niche: molecular processes occurring within erythroblastic islands.Transfus Clin Biol. 2010; 17: 110-111
- Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts.Haematologica. 2018; 103: 1593-1603
Bhoopalan SV, Huang LJ, Weiss MJ. Erythropoietin regulation of red blood cell production: from bench to bedside and back, F1000Res, 9, 2020, F1000 Faculty Rev-1153.
- Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.Blood. 2010; 116: 3039-3048
- JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.Cell. 1993; 74: 227-236
- Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.Blood. 2008; 111: 4511-4522
- Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.Blood. 2008; 112: 875-885
- Erythropoietin action in stress response, tissue maintenance and metabolism.Int J Mol Sci. 2014; 15: 10296-10333
- TGF-beta signaling in the control of hematopoietic stem cells.Blood. 2015; 125: 3542-3550
- Negative autoregulation by Fas stabilizes adult erythropoiesis and accelerates its stress response.PLoS One. 2011; 6: e21192
- Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and beta-thalassemia.Int J Mol Sci. 2021; 22: 827
- New insights into iron regulation and erythropoiesis.Curr Opin Hematol. 2015; 22: 199
- Stress erythropoiesis: new signals and new stress progenitor cells.Curr Opin Hematol. 2011; 18: 139-145
- beta-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis.Int J Biochem Cell Biol. 2014; 51: 89-92
- Advances in understanding erythropoiesis: evolving perspectives.Br J Haematol. 2016; 173: 206-218
- Ineffective erythropoiesis and regulation of iron status in iron loading anaemias.Br J Haematol. 2016; 172: 512-523
- Intestinal HIF2alpha promotes tissue-iron accumulation in disorders of iron overload with anemia.Proc Natl Acad Sci U S A. 2013; 110: E4922-E4930
- Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.Blood. 2007; 109: 5027-5035
- Macrophages support pathological erythropoiesis in polycythemia vera and beta-thalassemia.Nat Med. 2013; 19: 437-445
- HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia.Nature. 2014; 514: 242-246
- Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1.Nature. 1999; 401: 489-493
- Novel players in beta-thalassemia dyserythropoiesis and new therapeutic strategies.Curr Opin Hematol. 2016; 23: 181-188
- Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias.Blood. 2007; 109: 2693-2699
- Heme-regulated eIF2α kinase in erythropoiesis and hemoglobinopathies.Blood. 2019; 134: 1697-1707
- Iron metabolism under conditions of ineffective erythropoiesis in beta-thalassemia.Blood. 2019; 133: 51-58
- Lack of Gdf11 does not improve anemia or prevent the activity of RAP-536 in a mouse model of beta-thalassemia.Blood. 2019; 134: 568-572
- Growth differentiation factor 15 in erythroid health and disease.Curr Opin Hematol. 2010; 17: 184-190
- Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with beta thalassemia intermedia.Blood Cells Mol Dis. 2011; 47: 232-234
- Growth differentiation factor 15 (GDF15) and erythropoietin (EPO) levels in beta talassemia major patients.Blood. 2008; 112: 1881
- Hypercoagulability and vascular disease.Hematol Oncol Clin North Am. 2018; 32: 237-245
- Increased circulating platelet aggregates in thalassaemia.Southeast Asian J Trop Med Public Health. 1981; 12: 556-560
- In vivo platelet activation in β-thalassemia major reflected by increased platelet-thromboxane urinary metabolites.Blood. 1991; 77: 1749-1753
- Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells.Thromb Haemost. 2008; 100: 864-870
- Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity.Br J Haematol. 1978; 40: 255-263
- The role of phosphatidylserine in recognition and removal of erythrocytes.Cell Mol Biol (Noisy-le-grand). 2004; 50: 147-158
- Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes.Br J Haematol. 2001; 112: 48-50
- Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes.Am J Hematol. 1993; 44: 63-65
- Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia.Thromb Haemost. 1996; 76: 322-327
- Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.Br J Haematol. 2000; 111: 467-473
- The hypercoagulable state in thalassemia.Blood. 2002; 99: 36-43
- Alterations in vascular endothelial cell-related plasma proteins in thalassaemic patients and their correlation with clinical symptoms.Thromb Haemost. 1995; 74: 1045-1049
- Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia.Am J Hematol. 2002; 70: 100-106
- Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors.Haematologica. 2001; 86: 1112-1113
- Thalassemia and hypercoagulability.Blood Rev. 2008; 22: 283-292
- Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin.Thromb Res. 2018; 172: 61-66
- Hemostatic and thrombotic markers in patients with hemoglobin E/beta-thalassemia disease.Am J Hematol. 2007; 82: 1001-1004
- Thalassemia and the hypercoagulable state.Thromb Res. 2013; 132: 637-641
- Lupus anticoagulant and anticardiolipin antibodies in polytransfused beta thalassemia major.Hematology. 2006; 11: 287-290
- Endothelial nitric oxide synthase gene intron 4 variable number tandem repeat polymorphism in beta-thalassemia major: relation to cardiovascular complications.Blood Coagul Fibrinolysis. 2015; 26: 419-425
- Iron metabolism and development of atherosclerosis.Circulation. 2002; 106 ([author reply: e7]): e7
- Heart disease in thalassemia intermedia.Hemoglobin. 2009; 33: S170-S176
- Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran.Thromb Haemost. 2006; 96: 488-491
- Splenectomy and thrombosis: the case of thalassemia intermedia.J Thromb Haemost. 2010; 8: 2152-2158
- Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.Blood. 2010; 115: 1886-1892
- Cerebral infarction in beta-thalassemia intermedia: breaking the silence.Thromb Res. 2012; 130: 695-702
- Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia.J Thromb Haemost. 2010; 8: 54-59
- Brain magnetic resonance angiography in splenectomized adults with beta-thalassemia intermedia.Eur J Haematol. 2011; 87: 539-546
- Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with beta-thalassaemia intermedia.Thromb Haemost. 2010; 103: 989-993
- The frequency of silent cerebral ischemia in patients with transfusion-dependent beta-thalassemia major.Ann Hematol. 2016; 95: 135-139
- High incidence of silent cerebral infarcts in adult patients with beta thalassemia major.Thromb Res. 2016; 144: 119-122
- Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT). Nicosia (Cyprus).Thalassaemia International Federation. 2013;
- Normalized coagulation markers and anticoagulation proteins in children with severe β-thalassemia disease after stem cell transplantation.Thromb Res. 2012; 129: 765-770
- Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with β-thalassemia following bone marrow transplantation.Ann Hematol. 2017; 96: 1741-1747
- How I diagnose and treat venous thromboembolism in sickle cell disease.Blood J Am Soc Hematol. 2018; 132: 1761-1769
- Rivaroxaban use in patients with hemoglobinopathies.Hemoglobin. 2017; 41: 223-224
- Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells.Am J Hematol. 2008; 83: 842-845
- Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.Br J Haematol. 2007; 139: 3-13
- Serum levels of S100b and NSE proteins in patients with non-transfusion-dependent thalassemia as biomarkers of brain ischemia and cerebral vasculopathy.Int J Mol Sci. 2017; 18: 2724
- Development of a thalassemia-related thrombosis risk scoring system.Am J Hematol. 2019; 94: E207-E209
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
